Tamir Miloh

Dr. Tamir Miloh joins us as the director of pediatric liver transplant medicine at the Miami Transplant Institute (MTI), a unique aliation between Jackson Health System and UHealth – University of Miami Health System. Dr. Miloh is actively involved in the clinical investigation of various pediatric liver diseases such as primary sclerosing cholangitis (PSC), autoimmune hepatitis, Wilson’s disease, metabolic diseases, biliary atresia, non-alcoholic fatty liver disease (NAFLD), and acute liver failure. He has a special interest in increasing children’s access to transplant, improving patients’ adherence, and transition of care to adult providers. He completed a residency in Pediatrics at St. Christopher’s Hospital for Children in Philadelphia with subsequent fellowship training in pediatric gastroenterology, hepatology, and liver transplant at Mount Sinai Hospital in New York. After ve years, he established a new pediatric liver transplant program at Phoenix Children’s Hospital in collaboration with the Mayo Clinic. He served as the director of pediatric hepatology and liver transplant and was an associate professor at the University of Arizona and the Mayo Clinic, until his recruitment to Texas Children’s Hospital and the Baylor College of Medicine in 2015 as the director of pediatric hepatology and transplant and advanced pediatric hepatology fellowship. Dr. Miloh has been the primary investigator and co-investigator in numerous NIH, FDA, and pharmacy-initiated studies of children with chronic liver disease. He has leadership roles in United Network of Organ Sharing (UNOS), Studies of Pediatric Liver Transplantation (SPLIT), North American Society of Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN), American Association for the Study of Liver Disease (AASLD), and the Wilson’s Disease Association.